No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Cadrenal Therapeutics | 8-K: Cadrenal Therapeutics Reports First-Quarter 2025 Financial Results and Provides Corporate Update
Cadrenal Therapeutics 1Q Loss $3.85M >CVKD
Cadrenal Therapeutics 1Q Loss/Shr $2.09 >CVKD
Cadrenal Therapeutics | 10-Q: Quarterly report
Cadrenal Therapeutics to Present at Inaugural Centri Capital Conference at Nasdaq
Express News | Cadrenal Therapeutics Inc - Files Prospectus Supplement for $2.17 Mln Atm Offering - SEC Filing